About Plasma alpha-L-fucosidase
Plasma alpha-L-fucosidase (FUCA2) is a protein
from Homo sapiens identified by UniProt accession
Q9BTY2, 467 residues long.
MolForge cross-references it against 0 known binders and
44 disease associations.
Target properties
| Protein name | Plasma alpha-L-fucosidase |
| UniProt accession | Q9BTY2 |
| Gene | FUCA2 |
| Organism | Homo sapiens |
| Length | 467 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (44)
Diseases linked to this target (Open Targets).
- blood protein measurement · score 0.32
- pulse pressure measurement · score 0.26
- PHF-tau measurement · score 0.13
- Myopia · score 0.11
- pathological myopia · score 0.11
- neoplasm · score 0.08
- cancer · score 0.08
- hepatocellular carcinoma · score 0.08
- chronotype measurement · score 0.03
- adolescent idiopathic scoliosis · score 0.02
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9BTY2-F1 | alphafold | PREDICTED | 93.63 | — |
Amino-acid sequence (467 residues)
MRPQELPRLA FPLLLLLLLL LPPPPCPAHS ATRFDPTWES LDARQLPAWF DQAKFGIFIH WGVFSVPSFG SEWFWWYWQK EKIPKYVEFM KDNYPPSFKY EDFGPLFTAK FFNANQWADI FQASGAKYIV LTSKHHEGFT LWGSEYSWNW NAIDEGPKRD IVKELEVAIR NRTDLRFGLY YSLFEWFHPL FLEDESSSFH KRQFPVSKTL PELYELVNNY QPEVLWSDGD GGAPDQYWNS TGFLAWLYNE SPVRGTVVTN DRWGAGSICK HGGFYTCSDR YNPGHLLPHK WENCMTIDKL SWGYRREAGI SDYLTIEELV KQLVETVSCG GNLLMNIGPT LDGTISVVFE ERLRQMGSWL KVNGEAIYET HTWRSQNDTV TPDVWYTSKP KEKLVYAIFL KWPTSGQLFL GHPKAILGAT EVKLLGHGQP LNWISLEQNG IMVELPQLTI HQMPCKWGWA LALTNVI
Explore Plasma alpha-L-fucosidase with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets